Clinical Trial Update: Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

View source ↗

Summary

This clinical trial update describes a study evaluating biomarkers to predict treatment response in samples from patients with early-stage non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IA Non-small Cell Lung Cancer, Stage IB Non-small Cell Lung Cancer | Status: NOT_YET_RECRUITING